Список литературы

1. Lauze M., Daneaul J-F., Duval C. The Effects of Physical Activity in Parkinson’s Disease. Journal of Parkinson’s Disease 6 (2016) 685–698
2. Sturkenboom I, Thijssen M, Gons-van de Elsacker J, Jansen I, Maasdam A, Schulten M et al. Guidelines for Occupational Therapy in Parkinson's Disease Rehabilitation. Nijmegen/Miami:ParkinsonNet/NPF;2011.
3. Keus SHJ, van der Wees Ph, Nieuwboer AN, Jones D, Graziano M, Graham L et al. European guideline for physiotherapy in parkinson's disease. Neurorehabil Neural Repair 2012; XX(X):13 (pdf of poster: www.appde.eu/pdfs/Survey_poster_ParkinsonNet.pdf)
4. Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M. Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research.MovDisord2007;22(4):451-460.
5. Keus SHJ, Hendriks HJM, Bloem BR, Bredero-Cohen AB, de Goede CJT, van Haaren M et al. KNGF Guidelines for physical therapy in Parkinson's disease. Ned Tijdschr Fysiother 2004; 114(3(Suppl)):www.appde.eu.
6. Bloem BR, van Laar T, Keus SHJ, de Beer H, Poot E, Buskens E et al. Multidisciplinary Guideline 'Parkinson's disease' [in Dutch]. Alphen aan den Rijn: Van Zuiden Communications; 2010.
7. NICE. Parkinson's disease. Diagnosis and management in primary and secondary care (NICE Clinical Guideline 35). London, UK: National collaborating centre for chronic conditions; 2006.
8. Dutch Patient Association. Quality criteria from a patient perspective - Parkinson's disease [Dutch]. Available from: www parkinson- vereniging nl/media/kwaliteitscriteria_parkinson2009 pdf 2009.
9. Grosset KA, Grosset DG. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Mov Disord 2005; 20(5):616-619.
10. Hasson F, Kernohan WG, McLaughlin M, Waldron M, McLaughlin D, Chambers H et al. An exploration into the palliative and end-of-life experiences of carers of people with Parkinson's disease. Palliat Med 2010; 24(7):731-736.
11. Hohler AD, Tsao JM, Katz DI, Dipiero TJ, Hehl CL, Leonard A et al. Effectiveness of an inpatient movement disorders program for patients with atypical parkinsonism. Parkinsons Dis 2012; 2012:871974.
12. Aerts MB, Esselink RA, Post B, van de Warrenburg BP, Bloem BR. Improving the diagnostic accuracy in parkinsonism: a three-pronged approach. Pract Neurol 2012; 12(2):77-87.
13. Leibson CL, Maraganore DM, Bower JH, Ransom JE, O'Brien PC, Rocca WA. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord 2006; 21(4):446-455.
14. Jones JD, Malaty I, Price CC, Okun MS, Bowers D. Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 2012; 18(10):1073-1078.
15. Martignoni E, Godi L, Citterio A, Zangaglia R, Riboldazzi G, Calandrella D et al. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. Neurological Sciences 2004; 25(2):66-71.
16. Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003; 60(1):87-93.
17. Salisbury C. Multimorbidity: redesigning health care for people who use it. Lancet 2012; 380(9836):7-9.
18. Смоленцева И.Г., Кривонос О.В., Амосова Н.А., Чупина Л.П. Причины госпитализаций и смерти при болезни Паркинсона по результатам 3-х летнего проспективного исследования. Клиническая неврология №2, 2013/ С.6-10
19. Шток В.Н., Иванова-СмоленскаяИ.А., Левин О.С. и др.Экстрапирамидные расстройства. М: МЕДпресс-информ 2002; 606.
20. Левин О.С., Смоленцева И.Г. Немоторные проявления болезни Паркинсона. М., 2007. С. 24.
21. Смоленцева И.Г. Моторные и немоторные нарушения на развернутой и поздних стадиях болезни Паркинсона: автореф. дис. докт. мед. наук. – М., 2011. – 46 с.
22. Chaudhuri K. Ray, Prieto-Jurcynska C., Naidu Y,. Mitra T., Frades-Payo B., Tluk S., Ruessmann A., Odin P., Macphee G, Stocchi R, Ondo W., Sethi K., Schapira A. H.V, Martinez-Martin P., The Nondeclaration of Nonmotor Symptoms of Parkinson’s Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire. Movement Disorders. Vol. 00, No. 00, 2010, pp. 000–000_ 2010. Movement Disorder Society.
23. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8:464–474.
24. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19(1):155-162.
25. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68(5):384-386.
26. Taylor KS, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78(8):905-906.
27. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. [Parkinson disease is more prevalent than people think. Research results]. Ned Tijdschr Geneeskd 2009; 153(3):63- 68.
28. von Campenhausen S., Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15(4):473-490.
29. Lindgren P, von CS, Spottke E, Siebert U, Dodel R. Cost of Parkinson's disease in Europe. Eur J Neurol 2005; 12 Suppl 1:68-73.
30. Findley LJ. The economic impact of Parkinson's disease. Parkinsonism Relat Disord 2007; 13 Suppl:S8-S12.
31. Keranen T, Kaakkola S, Sotaniemi K, Laulumaa V, Haapaniemi T, Jolma T et al. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 2003; 9(3):163-168.
32. Kiyohara C, Kusuhara S. Cigarette smoking and Parkinson's disease: a meta-analysis. Fukuoka Igaku Zasshi 2011; 102(8):254-265.
33. Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord 2012; 27(8):947-957.
34. Crosiers D, Theuns J, Cras P, Van BC. Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes. J Chem Neuroanat 2011; 42(2):131-141.
35. Berardelli A, Wenning GK, Antonini A. et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013 Jan;20(1):16-34.
36. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004; 19(9):1020-1028
37. Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor uctuations. Mov Disord 2006; 21(9):1384-1395.
38. Rajput AH, Uitti RJ, Rajput A, Offord KP. Mortality in Parkinson’s disease. Mov Disord. 2010;25:507–508.
39. Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS et al. The evolution of disability in Parkinson disease. Mov Disord 2008; 23(6):790- 796.
40. Oertel W, Berardelli A, Bloem B, et al. Joint EFNS/MDS-ES guidelines on early (uncomplicated) and late (complicated) Parkinson's disease. Blackwell Publishing Ltd.; 2011. 217-267.
41. Olanow CW, Brin MF. Surgical therapies for Parkinson’s disease: a physician’s perspective. Adv Neurol 2001;86:421–433.
42. Deutschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep brain stimulation for Parkinson’s disease. N Engl J Med 2006;355:896–908.
43. Volkmann J. Update on surgery for Parkinson's disease. Curr Opin Neurol 2007; 20(4):465-469.
44. Okun MS, Foote KD. Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother 2010; 10(12):1847-1857.
45. Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M. Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord 2007; 22(4):451-460.
46. Morris ME. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys Ther 2000; 80(6):578-597.
47. Rochester L, Nieuwboer A, Lord S. Physiotherapy for Parkinson's disease: de ning evidence within a framework for intervention. Neurodegen Dis Manage 2011; 1:57-65.
48. Нодель, М.Р. Физическая реабилитация пациентов с болезнью Паркинсона / М.Р. Нодель // В помощь неврологами реабилитологам. М., 2010. – 24 с.
49. Кадыков, А. С. Реабилитация неврологических больных / A. С. Кадыков, Л. А. Черникова, Н. В. Шахпаронова. – М: МЕДпресс-информ, 2008. – 560 с.
50. World Health Organization (WHO). International Classification of Functioning, Disability and Health (ICF). www who int/classifications/ icf/en/index html [ 2007 [cited 12 A.D. Feb. 22];
51. Keus SHJ, Munneke M, Graziano M, et al. European Physiotherapy Guideline for Parkinson’s disease. 2014; KNGF/ParkinsonNet, the Netherlands
52. Nicolien M., Van der Kolk, King L.A. Effects of exercise on mobility in people with Parkinson’s disease. Movevent Disorders 2013; 11: 1587—1596.
53. Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM. Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review. J Parkinsons Dis. 2015;5(1):21-41.
54. Амосова Н.А., Смоленцева И.Г. Методы реабилитации при болезни Паркинсона. Журнал неврологии и психиатрии им Корсакова, 2014. –N6 (2). –C.80 -86.
55. de Goede CJ, Keus SH, Kwakkel G, Wagenaar RC. The effects of physical therapy in Parkinson’s disease: a research synthesis. Arch Phys Med Rehabil. 2001;82:509–515
56. Deane KH, Jones D, Ellis-Hill C, Clarke CE, Playford ED, Ben-Shlomo Y. A comparison of physiotherapy techniques for patients with Parkinson’s disease. Cochrane Database Syst Rev. 2001(1):CD002815.
57. Crizzle AM, Newhouse IJ. Is physical exercise beneficial for persons with Parkinson’s disease? Clin J Sport Med 2006;16:422– 425.
58. Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M. Evidence-based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research. Mov Disord 2007;22:451–460.
59. Kwakkel G, de Goede CJ, van Wegen EE. Impact of physical therapy for Parkinson’s disease: a critical review of the literature. Parkinsonism Relat Disord 2007;13(suppl 3):S478–S487.
60. Goodwin V, Richards SH, Taylor RS, Taylor A, Campbell JL. The effectiveness of exercise interventions for people with Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 2008;23:631–640.
61. Lee SJ, Yoo JY, Ryu JS, Park HK, Chung SJ. The effects of visual and auditory cues on freezing of gait in patients with Parkinson disease. Am J Phys Med Rehabil. 2012;91:2–11.
62. Dibble LE, Hale TF, Marcus RL, Gerber JP, LaStayo PC. High intensity eccentric resistance training decreases bradykinesia and improves quality of life in persons with Parkinson’s disease: a preliminary study. Parkinsonism Relat Disord 2009;15: 752-757.
63. Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst Rev. 2010;(1):CD007830.
64. Allen NE, Sherrington C, Paul SS, Canning CG. Balance and falls in Parkinson’s disease: a meta-analysis of the effect of exercise and motor training. Mov Disord. 2011;26:1605–1615.
65. de Dreu MJ, van der Wilk AS, Poppe E, Kwakkel G, van Wegen EE. Rehabilitation, exercise therapy and music in patients with Parkinson’s disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinsonism Relat Disord. 2012;18(Suppl 1):S114–S119.
66. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson’s disease. Cochrane Database Syst Rev. 2012;8:CD002817.
67. Brienesse LA, Emerson MN. Effects of resistance training for people with Parkinson’s disease: a systematic review. JAmMedDirAssoc. 2013;14:236–241.
68. Юнищенко Н. А. Нарушения ходьбы и постуральной устойчивости при болезни Паркинсона: автореф. дис канд. мед. наук. М., 2005.
69. Карпова, Е.А. Постуральные нарушения при болезни Паркинсона / Е.А. Карпова, И.А. Иванова-Смоленская, Л.А. Черникова, С.Н. Иллариошкин // Неврологический журнал. – 2003. – № 2. – С.36 – 41.
70. Левин О. С. Нарушения ходьбы: механизмы, классификация, принципы диагностики и лечения // Экстрапирамидные расстройства / под ред. В. Н. Штока, И. А. Ивановой-Смоленской, О. С. Левина. М.: Медпресс-информ, 2002. С. 473- 494.
71. Литвиненко, И.В. Новые возможности коррекции нарушений ходьбы на поздних стадиях болезни Паркинсона/ И.В. Литвиненко, Р.Р. Халимов, А.Г. Труфанов [и др.]// Успехи геронтол. – 2012. – Т 25. – № 2. – С. 267-274.
72. Похабов, А.В. Реабилитация больных с нарушениями ходьбы при паркинсонизме / А.В. Похабов // Журнал неврологии и психиатрии им.С.С.Корсакова. – 2012. – Т. 10. – № 2. – С. 20-24.
73. Yen C. Y., Lin K. H., Hu M. H., Wu R. M., Lu T. W., Lin C. H. (2011). Effects of virtual reality-augmented balance training on sensory organization and attentional demand for postural control in people with Parkinson disease: a randomized controlled trial. Phys. Ther. 91, 862–874.10.2522/ptj.2010005
74. Mirelman A, Maidan T, Herman T, Deutsch JE, Giladi N, Hausdorff JM. Virtual realist for gait training: Can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson’s disease? J Gerontol A Biol Sci Med Sci 2011;66:234–240.
75. Pompeu JE, Mendes FA, Silva KG, et al. Effect of Nintendo Wiibased motor and cognitive training on activities of daily living in patients with Parkinson’s disease: a randomized clinical trial. Physiotherapy 2012;98:196–204.
76. dos Santos A, Pegollo F, Alencar R, Avanzi R, Pompeu JE. A new tool for assessment and balance training of patients with Parkinson's disease based on low cost commercial Wii balance Board. Mov Disord. 2012;27(Suppl 1):898.
77. Esculier JF, Vaudrin J, eriault P, Gagnon K, Tremblay LE. Home-based balance training programme using Wii Fit with balance board for Parkinson's disease: a pilot study. J Rehabil Med. 2012;44:144–150. doi: 10.2340/16501977-0922.
78. Mohlman J, Chazin D, Georgescu B. Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson’s disease. J Geriatr Psychiatry Neurol 2011;24:91–97.
79. Disbrow EA, Russo KA, Higginson CI, et al. Efficacy of tailored computer-based neurorehabilitation for improvement of movement initiation in Parkinson’s disease. Brain Res 2012;1452:151–164.
80. Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson’s disease: evidence from neuroimaging [serial online]. Front Neurol 2011;2:82.
81. Sammer G, Reuter I, Hullmann K, Kaps M, Vaitl D. Training of executive functions in Parkinson’s disease. J Neurol Sci 2006;248:115–119.
82. Paris AP, Saleta HG, de la Cruz Crespo Maraver M, et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Mov Disord 2011;26:1251–1258.
83. Амосова Н.А., Смоленцева И.Г., Карпова О.В., Кривонос О.В. Когнитивная реабилитация при болезни Паркинсона. Клиническая неврология, 2014.-№3.-С36- 42
84. ЗахаровВ.В. Медикаментозные и немедикаментозные методы коррекции когнитивных нарушений // Consilium Medicum. - 2014.Т.16. - №2. – С.24-29.
85. Kalf, H., de Swart, B., et al. Guidelines for Speech-Language Therapy in Parkinson’s Disease Nijmegen (The Netherlands); Miami (U.S.A.): ParkinsonNet (The Netherlands); National Parkinson Foundation (U.S.A.), (2011), 1-137.
86. Chou YH, Hickey PT, Sundman M, Song AW, Chen NK. Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2015;72(4):432–40.
87. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al. Movement Disorder Society-sponsored revision of the Unied Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23(15):2129- 2170.
88. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71: 670–676
89. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clini- copathological study. J Neurol Neurosurg Pshychiatry. 1996; 60: 615–620.
90. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain. 2007;130: 1552–15565.
91. A Schrag, Y Ben-Shlomo, and NP Quinn Prevalence of progressive supranuclear palsy and multiple system atrophy; a cross sectional study. Lancet. 2006; 354: 1771-1775
92. Zampieri C, Di Fabio RP. Progressive supranuclear palsy: disease profile and rehabilitation strategies. PhysTher. 2006; 866: 870–880

Приложение 1.